Page 1

FOR IMMEDIATE RELEASE ● Cardinal Health reports third - quarter results for fiscal year 2021 Revenue was flat at $ 39.3 billion GAAP¹ operating earnings decreased to $ 473 million , GAAP diluted EPS decreased to $ 0.40 Non - GAAP operating earnings decreased 4 % to $ 689 million , non - GAAP diluted EPS decreased 6 % to $ 1.53 Company narrowed FY21 earnings guidance DUBLIN , Ohio , May 6 , 2021 – Cardinal Health ( NYSE : CAH ) today reported third - quarter fiscal year 2021 revenue of $ 39.3 billion , in - line with the third quarter of last year . Third - quarter GAAP operating earnings decreased 16 % to $ 473 million , primarily due to the write - down of the net assets held for sale from the planned divestiture of the Cordis business . Third - quarter GAAP diluted earnings per share ( EPS ) decreased to $ 0.40 , due to the previously - disclosed tax effect of the litigation charge in the first quarter . Q3 FY21 summary Non - GAAP operating earnings decreased 4 % to $ 689 million in the quarter due to the negative impact from COVID - 19 , primarily concentrated in the Pharmaceutical segment . Non - GAAP diluted EPS decreased 6 % to $ 1.53 in the quarter , reflecting a higher non - GAAP effective tax rate , partially offset by lower interest expense . " We remain focused on serving our customers and their patients and continue to advance our strategic priorities , " said Mike Kaufmann , CEO of Cardinal Health . " With our resilient business model and strong fundamentals , we are navigating the effects of the pandemic and finding opportunities to adapt , innovate and invest for future growth . " Revenue Operating earnings Non - GAAP operating earnings Net earnings attributable to Cardinal Health , Inc. Non - GAAP net earnings attributable to Cardinal Health , Inc. Effective Tax Rate Non - GAAP Effective Tax Rate Diluted EPS attributable to Cardinal Health , Inc. Non - GAAP diluted EPS attributable to Cardinal Health , Inc. Cardinal Health Essential to care ™ Q3 FY21 $ 39.3 billion $ 473 million $ 689 million $ 119 million $ 451 million Exhibit 99.1 72.8 % 31.2 % $ 0.40 $ 1.53 Q3 FY20 $ 39.2 billion $ 562 million $ 719 million $ 350 million $ 474 million 26.8 % 25.7 % $ 1.19 $ 1.62 Y / Y - % ( 16 ) % ( 4 ) % N.M. ( 5 ) % N.M. ( 6 ) %